Excess weight has been identified as a key factor in cardiovascular-renal-metabolic syndromeJune 9, 2026
News The RAND study highlights the standards of the use of GLP-1 drugs and side effectsBy healthtostAugust 6, 20250Almost 12% of Americans used GLP-1 drugs for weight loss, including about one fifth of women aged 50 to 64,…
